Hôpital Saint Antoine AP-HP
70 currently recruiting clinical trials
Phase 3
Multiple myeloma
#NCT05623020
#2024-514139-50-00
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required number of previous lines of therapy
None
1
2
Required previous treatments
Systemic Treatment-Naive
Proteasome inhibitor
Immunomodulator
Hôpital Saint Antoine AP-HP (Paris)
Pfizer
Phase 3
Multiple myeloma
#NCT05020236
#2023-509208-14-00
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Saint Antoine AP-HP (Paris)
Pfizer
Phase 3
Multiple myeloma
#NCT06561854
#2024-510981-18-00
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required central nervous system lesions
None
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
Allogeneic stem cell transplant
Hôpital Saint Antoine AP-HP (Paris)
Assistance Publique - Hôpitaux de Paris
Phase 3
Stomach and esophageal cancer
#NCT06768164
Required histologic types
Stomach
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Surgery
Hôpital Saint Antoine AP-HP (Paris)
Assistance Publique - Hôpitaux de Paris
Phase 3
Lymphoma
#NCT06091865
#2022-502785-25-00
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Required central nervous system lesions
None
Required immunophenotypic profiles
CD20
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Hôpital Saint Antoine AP-HP (Paris)
Regeneron Pharmaceuticals
Phase 3
Lymphoma
#NCT06091865
#2022-502785-25-00
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Required central nervous system lesions
None
Required immunophenotypic profiles
CD20
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Saint Antoine AP-HP (Paris)
Regeneron Pharmaceuticals
Phase 3
Colon cancer
Rectal cancer
#NCT06997497
#2024-517232-22-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
KRAS G12C
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Saint Antoine AP-HP (Paris)
Merck Sharp & Dohme LLC
Phase 3
Colon cancer
Rectal cancer
#NCT06662786
#2024-513852-13-00
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
BRAF
HER2
KRAS G12C
KRAS non G12C
MSI/dMMR
NRAS
Hôpital Saint Antoine AP-HP (Paris)
Janssen
Phase 3
Colon cancer
Rectal cancer
#NCT04120701
#2024-515297-27-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Surgery
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Surgery
Excluded previous treatments at localized stage
Chemotherapy
Radiotherapy
Excluded previous treatments at advanced or metastatic stage
Chemotherapy
Radiotherapy
Hôpital Saint Antoine AP-HP (Paris)
CHU Dijon
Phase 3
Acute leukemia
#NCT05429632
#2024-512752-38-00
Required histologic types
Acute myeloid leukemia (AML)
Required number of previous lines of therapy
None
Hôpital Saint Antoine AP-HP (Paris)
Priothera SAS